Job Location : Boston,MA, USA
Home > Job Postings > Senior Director, Pharmacovigilance and Drug Safety, Risk Management and Safety Governance
Xenon Pharmaceuticals (NASDAQ:XENE) is a neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing innovative therapeutics to improve the lives of people living with neurological and psychiatric disorders. We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team.
What We Do:
We are advancing an exciting product pipeline to address indications with high unmet medical need, including epilepsy and depression. Our flagship azetukalner program represents the most advanced potassium channel modulator in clinical development for multiple indications. Building upon the positive results and compelling data from our Phase 2b “X-TOLE” study in adult patients with focal epilepsy, our Phase 3 epilepsy program includes multiple clinical trials evaluating azetukalner in patients with focal onset seizures and primary generalized tonic-clonic seizures. In 2024, we are planning to initiate a Phase 3 azetukalner program in major depressive disorder, based on topline data from our Phase 2 “X-NOVA” clinical trial. In addition, we are proud of the leading-edge science coming out of our discovery labs, including early-stage research programs that leverage our extensive ion channel expertise and drug discovery capabilities to identify validated drug targets and develop new product candidates. Backed by a strong balance sheet to support our growth plans, we continue to build a fully integrated, premier neuroscience company with strong discovery, clinical development, corporate, and commercial operations.
About the Role:
We are seeking a Senior Director, Pharmacovigilance and Drug Safety, Risk Management and Safety Governance, to join Xenon's department of Drug Safety and Pharmacovigilance (DSPV). This position will lead Xenon's risk management and safety governance strategy and operations by ensuring ongoing compliance with departmental procedures and global drug safety regulations throughout product lifecycle from First-in-Human (FIH) through post-marketing stages of development. The incumbent is responsible for fortifying a strong risk management infrastructure by developing, executing, and leading effective risk mitigation strategies for Xenon's clinical assets and future marketed products. The individual will author risk management documents, review relevant risk management sections of other documents, contribute to aggregate safety reports, and, when necessary, assist in responding to information requests from Health Authorities for Xenon products. In situations where advanced safety monitoring and/or reporting is required [i.e. – Events of Special Interest, Risk Management Plans (RMP/RMMs), Post Approval Studies (PAS), Risk Evaluation and Mitigation Strategies (REMS), etc.], the Senior Director will engage the Safety Governance Team and lead the development and implementation of any internal procedures, labeling/marketing materials, or reports for Health Authorities that are necessary to ensure the safe use of a Xenon product. This individual will participate in cross-functional Safety Governance meetings, provide guidance on industry best practices and regulatory requirements for risk management activities, and collaborate with colleagues in Clinical Development, Trial Operations, Regulatory Affairs, Medical Affairs, Clinical Pharmacology, Biostatistics & Programming, Quality Assurance, and Legal departments. This position communicates regularly with Xenon senior management regarding any risk identification, mitigation, or compliance finding that potentially impacts the benefit-risk profile of Xenon's clinical assets and marketed products.
This position reports to the Senior Vice President, Pharmacovigilance and Safety Officer and will be in Boston, MA, USA. We will consider other jurisdictions for exceptional candidates. The level of the position will be commensurate with the candidate's education and industry experience.
RESPONSIBILITIES:
o Lead development and implementation of REMS processes, documents, workflows, or training sessions necessary to support enhanced risk management activities in collaboration with Regulatory Affairs, Medical Affairs, Clinical Development, and Marketing teams and Health Authorities.
o Report or respond to Health Authorities Information Requests related to risk management activities.
o Communication with FDA and business partners in close collaboration with Regulatory Affairs, on matters related to the development and maintenance of REMS programs, REMS modifications, Assessment Reports, Dear Healthcare Professional Communications, Medication Guide, and inspections.
o Ensure adherence to REMS requirements and act where needed on REMS program's “Elements to Assure Safe Use” (ETASUs) through ongoing monitoring of established metrics, tracking logs, and documentation.
o Conduct vendor selection and contract negotiation/renewals according to company policies when the need to procure external providers has been determined by the REMS Team.
o Serve as a liaison between Xenon and its vendors, ensuring vendor compliance with REMS requirements and contractual obligations. Implement routine vendor audit processes and CAPAs with PV Operations & QA.
o Direct internal groups and external vendors or consultants pertaining to the development of the REMS Assessment Reports (RAR) and ensure the completeness and timely production according to the timetable for submission of assessments.
o Ensure implementation of FDA-approved changes to REMS programs and measures the effectiveness of those changes, revising REMS materials when identified internally or by FDA.
o Ensure SOPs concerning Xenon's risk management system are developed and maintained.
QUALIFICATIONS:
The base salary range for this role is $264,400 to $303,800 USD; we will consider above this range for exceptional candidates. Base salary is determined by a combination of factors including, but not limited to, education and other qualifications, years of relevant experience, and internal equity.
Our Total Rewards program includes base salary, target bonus, and stock options, as well as a full range of benefits including medical, dental, vision, short- & long-term disability, accidental death & dismemberment, and life insurance programs, Employee Assistance Program, travel insurance, and retirement savings programs with company matching contributions.
Xenon encourages time to rest and re-charge through vacation, personal days, sick days, and an end-of-year company shutdown. Xenon highly values employee development and has an expanding Training, Learning & Development program, including a Tuition Assistance program for advanced degrees.
As part of our hiring process, Xenon conducts background checks for finalist candidates. The types of checks conducted will vary depending on the relevance to the position.
US positions only: Xenon Pharmaceuticals USA Inc. participates in the E-Verify program in all states in which we hire.
#J-18808-Ljbffr